Top Tweets for #CanVECTORatASH2022
Abstract #3827: "The Safety and Efficacy of Anticoagulation for the Management of Isolated Distal Deep Vein #Thrombosis in Patients with #Cancer" in session 332 - @TzufeiWang @DellucAurelien @MarcCarrier1
https://t.co/h6fntPv85A
#CanVECTORatASH2022 #Research #DVT #VTE
Abstract #3823:"Performance of D-Dimers in Patients with Prior History of #VTE Based on Anticoagulation Status" in session 332 presented by @Vicky_Mai_
@grelegal @sudeeppappur @RodgerMarc @DellucAurelien @PhilWellsMD1 @SusanRKahn1
https://t.co/orTCWUic9D
#CanVECTORatASH2022
Abstract #3822: "Predictors of 90-Day Mortality in Patients with Acute #PulmonaryEmbolism– a 5-Year Retrospective Cohort Study of Patients in One Canadian 🇨🇦 Health Region" presented by @DrRufaroChitsik - @SYoungPharmD
https://t.co/BJdYmGIyPX
#CanVECTORatASH2022 #PE #Research
Abstract #3752: "Evaluating Doac Efficacy and Safety Against Vka/LMWH in Patients with Atrial Fibrillation and Malignancies: A Systemic Review and Meta-Analysis" in session 301 @DellucAurelien @TzufeiWang @MarcCarrier1
https://t.co/viZcXCdyU2
#CanVECTORatASH2022 #Research
At 4:30PM at #ASH22 , @TzufeiWang will present on "Frequently Asked Questions about Factor Xa Inhibitors" in an education session on "#Thrombosis Prevention and Treatment" in room R02-R05. Tune in!
https://t.co/P8xS4gQnNm
#CanVECTORatASH2022 #Research
If you're attending #ASH2022 today, don't miss @DebSiegal present the "case AGAINST #thrombophilia testing in many/most adults with unprovoked #thrombosis" in a Point/Counterpoint session in room 288-290 at 2:45PM CST !
https://t.co/3kN4RfKOeN
#CanVECTORatASH2022 #Research
Abstract #3503: "Clinical Benefits, Harms, and Cost-Effectiveness of Indefinite Anticoagulant Therapy for First Unprovoked #VTE: A Decision Analytic Modelling Study Clinically Relevant Abstract" presented by @FaizanK91 in session 901
https://t.co/MB7vElKziI
#CanVECTORatASH2022
Abstract #2517: "Blood Biomarkers for the Prediction of Venous Thromboembolism in Perioperative or Hospitalized Cancer Patients: A Systematic Review" in session 332 - @TzufeiWang @PhilWellsMD1 @daniellle_roy
https://t.co/vukFCCRenF
#CanVECTORatASH2022 #VTE #Research
Abstract #2514: "Trends in Drug Treatment of Outpatients with Acute Pulmonary Embolism - a 5-Year Retrospective Cohort Study in One Canadian 🇨🇦 Health Region" presented by @DrRufaroChitsik in session 332
https://t.co/8UdmJFV7VE
#CanVECTORatASH2022
Abstract #2510:"Comparative Analysis of 4 Risk Stratification Models to Identify Patients with Acute Pulmonary Embolism at Risk of Short Term Mortality in a Canadian 🇨🇦 Health Region" in session 332 @SYoungPharmD @DrRufaroChitsik
https://t.co/fgvzqDoIEF
#CanVECTORatASH2022 #PE
Abstract #2509: "The Risk of #Bleeding in Pregnant Women with Acute Venous Thromboembolism Treated with #Anticoagulants" presented by @camillemsimard in session 332 - @IsabelleMalhame @VTagalakis @AntoniosDouros
https://t.co/weXzUpWJr8
#CanVECTORatASH2022 #VTE #Research
Abstract #2488: "Longitudinal Characteristics of Anti-Platelet Factor 4 Immunoglobulin G in Vaccine-Induced Immune Thrombotic Thrombocytopenia" presented by @IshacNazyPhD in session 331 !
https://t.co/Q4kOwrO91G
#CanVECTORatASH2022 #ThrombosisBasicScience #VITT
Abstract # 2487: "Derivation and External Validation of Clinical Risk Assessment Model for #Cancer Associated #Thrombosis in Two Unique U.S. Healthcare Systems" in session 322 - @MarcCarrier1
https://t.co/kiA5oyfVkg
#CanVECTORatASH2022
Coming up at Noon CST, don't miss Dr. Michael Kovacs present on the Catheter 3 Study: A Prospective Study of Apixaban for Central Venous Catheter Associated UEDVT in #Cancer Patients" - Session 332; Room 291-292 at #ASH2022
https://t.co/iDUFSIePPN
#CanVECTORatASH2022 #Research
At 10:30AM CST at #ASH2022, don't miss @TzufeiWang presenting on the "Risk of VTE or Hemorrhage Among Individuals with Chronic Kidney Disease Taking a DOAC Compared to LMWH after a Hip or Knee Arthroplasty" - Session 904; Room 295-296
https://t.co/nmEeQaG8H4
#CanVECTORatASH2022
Poster #1187: "Anticoagulation and/or Antiplatelet in Thrombotic Antiphospholipid Syndrome with Previous Arterial Thromboembolism: A Retrospective Cohort" in Session 332 - @Ritaselby1
https://t.co/qfgcDMSPcb
#CanVECTORatASH2022 #Thrombosis #Research
Poster #1184: "Thrombophilia Gene Mutations for the Prediction of Venous Thromboembolism in Ambulatory Cancer Patients Receiving Chemotherapy" in Session 332 - @PhilWellsMD1 @TzufeiWang @MarcCarrier1
https://t.co/AZftSkydMG
#CanVECTORatASH2022 #Thrombosis #Research
If you're attending #ASH2022 tonight, be sure to check out the following abstracts / presentations involving members of our amazing @CanVECTOR community from 5:30-7:30 PM in Hall D 📢
https://t.co/r6614iIXQa
#CanVECTORatASH2022 #Thrombosis #Research
👇👇
If you're attending #ASH2022 , be sure to check out the outstanding thrombosis research from the @canvector community!
See the list of the @CanVECTOR member abstracts & presentations at the conference👇👇
https://t.co/WXGMLjSimv
#CanVECTORatASH2022
Last Seen Hashtags on Sotwe
antalyapasif
Seen from Turkey
creepshot
Seen from Switzerland
インターネット障害
Seen from United States
snapchat
Seen from Canada
babacık
Seen from Austria
istanbulcift
Seen from Turkey
母猪暴露
Seen from United States
prototype1006
Seen from United States
อุตรดิตถ์
Seen from Thailand
frequencies417Hz
Seen from United States
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
241.7M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.4M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
83.9M followers
Lady Gaga
@ladygaga
75.4M followers
Virat Kohli
@imvkohli
73.3M followers
Kim Kardashian
@kimkardashian
70.9M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.4M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers